TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive In Brief: Salmon To Step Down As Center Director; Becker To Relinquish Positions At MDACC September 4, 1998
TCL Archive In Brief: Carcinogenesis Task Force to Wrap Up Review In Four-Six Weeks; UCLA Groundbreaking Set October 28, 1977
TCL Archive Conversation with TCL:Demetri: Morcellation Worsens Outcomes In Patients with Undiagnosed Cancers November 21, 2014
